Abstract
Viruses as a whole are important pathogens. They have also been found to have a close association with certain human malignancies. Five types of herpesviruses were identified to be the causative agents in human diseases. They are herpes simplex virus (HSV) type 1, HSV-2, cytomegalovirus (CMV), Epstein Barr virus (EBV) and varicella zoster virus (VZV). These are DNA viruses capable of inducing biochemical changes in infected cells, which in most cases are triggered by virus induced or coded enzymes or proteins (Nahmias et al., 1981; Roizman, 1983). Several enzymes involved in DNA synthesis are known to be specified by some or all types of herpesvirus. A summary of these identified enzymes and the primary reactions they catalyze (Lemaster & Roizman, 1980; Blue & Stobbs, 1981; Cheng et al., 1982) is presented in Table 1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
AVERETT, D.R., LUBBERG, C., ELION, G.B. & SPECTOR, T. (1983). Ribonucleotide reductase induced by Herpes Simplex Type I Virus. Characterization of a distinct enzyme. J. biol. Chem., 258, 9831–9838.
BACCHETTI, S., EVELEGH, M.J., MUIRHEAD, B., SARTORI, C.S. & HUSZAR, D. (1984). Immunological Characterization of Herpes Simplex Virus Type I and II. Polypeptide(s) involved in viral ribonucleotide reductase activity. J. Virol., 49, 591–593.
BASTOW, K.F., DERSE, D.D. & CHENG, Y.-C. (1983). Susceptibility of phosphonoformic acid-resistant Herpes Simplex Virus variants to arabinosylnucleosides and aphidicolin. Antimicrob. Agents. Chemother., 23, 914–917.
BLUE, W.T. & STOBBS, D.G. (1981). Isolation of a protein kinase induced by Herpes Simplex Virus Type I. J. Virol., 38, 383–388.
BRUTLAG, D. & KORNBERG, A. (1972). Enzymatic synthesis of deoxyribonucleic acid. XXVI. A proofreading function for the 3′-5′ exonuclease activity in deoxyribonucleic acid polymerase. J. biol. Chem., 247, 241–248.
BURNS, W.H., SARSAL, R., SANTOS, G.W., LASKIN, O.L., LIETMAN, P.S., McLAREN, C. & BARRY, D.W. (1982). Isolation and characterization of resistant Herpes Simplex Virus after acyclovir therapy. Lancet, 421–423.
CHENG, Y.-C. (1977). A rational approach to the development of antiviral chemotherapy: Alternative substrates of Herpes Simplex Virus Type I and Type II thymidine kinase. Ann. N.Y. Acad. Sci., 18, 594–598.
CHENG, Y.-C. (1981). Molecular basis and pharmacological consideration of selective antiherpetic agent. In Herpetic Eye Diseases. Herausgegeban von R. Sundmacher (ed.), pp. 237–246, Munchen: J.F. Bergmann Verlag.
CHENG, Y.-C. (1983). HSV Thymidine Kinase dependent antiviral agent. In Antiviral Drugs and Interferon: The Molecular Basis of Their Activity. Y. Becker (ed.) (in press).
CHENG, Y.-C. & DERSE, D. (1981). Approaches and limitations in the development of selective antiherpes virus agents based on virus specified enzymes. In The Medicinal Chemistry Symposium 1981. J.B. Thomas (ed.), Amsterdam/New York/Oxford: Elsevier/North Holland (in press).
CHENG, Y.-C., GRILL, S., DERSE, D., CHEN, J.-Y., CARADONNA, S.J. & CONNER, K. (1981). Mode of action of Phosphonoformate as an antiherpes simplex agent. Biochim. biophys. Acta., 652, 90–98.
CHENG, Y.-C., NAKAYAMA, K., DERSE, D., BASTOW, K., RUTH, J., TAN, R.S., DUTSCHMAN, G., CARADONNA, S.J. & GRILL, S. (1982). Herpes virus specified enzymes: properties, physiological roles, and pharmacological implications. In: Herpesvirus, Clinical, Pharmacological and Basic Aspects, H. Shiota, Y.-C. Cheng & W.H. Prusoff (eds) pp. 47–56, Amsterdam/Oxford/Princeton: Excerpta Medica.
COEN, D.M., FURMAN, P.A., ASCHMAN, D.P. & SCHAFFER, P.A. (1983). Mutations in the Herpes Simplex Virus DNA polymerase gene conferring hypersensitivity to aphidicolon. Nuc. Acids Res., 11, 5287–5297.
COHEN, G.H. (1972). Ribonucleotide reductase activity of synchronized KB cells infected with Herpes Simplex Virus. J. Virol., 9, 408–418.
COHEN, G.H., FACTOR, M.N. & PONCE de LEON, M. (1974). Inhibition of Herpes Simplex Virus type II replication by thymidine. J. Virol., 14, 20–25.
CRUMPACKER, C.S., SCHNIPPER, I.E., MARLOWE, S.I., KOWALSKY, P.N., HERSHEY, B.J. & LEVIN, M.J. (1982). Resistance to antiviral drugs of Herpes Simplex Virus isolated from a patient treated with acyclovir. N. Engl. J. Med., 306, 343–346.
DARBY, G. & FIELD, H.J. (1984). Latency and acquired resistance — problems in chemotherapy of herpes infections. Pharmac. Ther., 23, 217–225.
DARBY, G., FIELD, H.J. & SALISBURY, S.A. (1981). Altered substrate specificity of Herpes Simplex Virus thymidine kinase confers acyclovir-resistance. Nature, 289, 81–83.
DERSE, D.D., BASTOW, K.F. & CHENG, Y.-C. (1982). Characterization of the DNA polymerases induced by a group of Herpes Simplex Virus type I variants selected for growth in the presence of phosphonoformic acid. J. biol. Chem., 257, 10251–10260.
DERSE, D.D. & CHENG, Y.-C. (1981). Herpes Simplex Virus type I DNA polymerase. Kinetic properties of the associate 3′-5′ exonuclease activity and its role in araAMP incorporation. J. biol. Chem., 256, 8525–8530.
DERSE, D.D., CHENG, Y.-C., FURMAN, P.A., ST. CLAIR, M.H. & ELION, G.B. (1981). Inhibition of purified human and Herpes Simplex Virus-induced DNA polymerase by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function. J. biol. Chem., 256, 11447–11451.
DUTIA, B.M. (1983). Ribonucleotide reductase induced by Herpes Simplex Virus has a virus-specified constituent. J. Gen. Virol., 64, 513–521.
ERIKSSON, B., LARSSON, A., HELGSTRAND, E., JOHANSSON, N.-G. & OBERG, B. (1980). Pyrophosphate analogues as inhibitors of Herpes Simplex Virus type I DNA polymerase. Biochim. biophys. Acta, 607, 53–64.
FIELD, H.J. & WILDY, P. (1978). The pathogenicity of thymidine kinase deficient mutants of Herpes Simplex Virus in mice. J. Hyg., 81, 267–277.
FRANK, K.B., CHIOU, J.-F. & CHENG, Y.-C. (1984b). Interaction of Herpes Simplex Virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl) guanine triphosphate. J. biol. Chem., 259, 1566–1569.
FRANK, K.B., DERSE, D.D., BASTOW, K.F. & CHENG, Y.C. (1984). Novel interaction of aphidicolin with Herpes Simplex Virus DNA polymerase and polymerase-associated exonuclease. J. biol. Chem. (in press).
HUSZAR, D. & BACHETTI, S. (1981). Partial purification and characterization of the ribonucleotide reductase induced by Herpes Simplex Virus infection of mammalian cells. J. Virol., 37, 580–588.
KNOPF, K.W. (1979). Properties of Herpes Simplex Virus DNA polymerase and characterization of its associated exonuclease activity. Eur. J. Biochem., 98, 231–244.
LANGELIER, Y. & BUTTIN, G. (1981). Characterization of ribonucleotide reductase induction in BHK-21/C13 Syrian hamster cell line upon infection by Herpes Simplex Virus (HSV). J. Gen. Virol., 57, 21–31.
LANGELIER, Y., DECHAMPS, M. & BUTTIN, G. (1978). Analysis of dCMP deaminase and CDP reductase levels in hamster cells infected by Herpes Simplex Virus. J. Virol., 26, 547–553.
LANIUNEN, H., GRASLUND, A. & THELANDER, L. (1982). Induction of a new ribonucleotide reductase after infection of mouse L cells with Pseudorabies virus. J. Virol., 41, 893–900.
LARDER, B.A., DERSE, D., CHENG, Y.-C. & DARBY, G. (1983). Properties of purified enzymes induced by pathogenic drug-resistant mutants of Herpes Simplex Virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. J. biol. Chem., 258, 2027–2033.
LEMASTER, S. & ROIZMAN, B. (1980). Herpes Simplex Virus Phosphoproteins II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion. J. Virol., 35, 798–811.
LIN, J.-C., SMITH, M.C., CHENG, Y.-C. & PAGANO, J.S. (1983). Epstein-Barr Virus: Inhibition of replication by three new drugs. Science, 221, 578–579.
LOPEZ, C., WANTANABI, K.A. & FOX, J.J. (1980). 2′-Fluoro-5-Iodo-Aracytosine, a potent and selective antiherpes agent. Antimicrob. Agents Chemother., 17, 803–806.
MAR, E.-C., PATEL, P.C., CHENG, Y.-C., FOX, J.J., WANTANABE, K.A. & HUANG, E.-S. (1984). Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro. J. Gen. Virol., 65, 47–53.
NAHMIAS, A.J., DOWDLE, W.R. & SCHINAZI, R.F. (1981). The Human Herpesviruses: An Interdisciplinary Perspective. New York: Elsevier.
NUTTER, L.M., GRILL, S.P. & CHENG, Y.-C. (1984). Can ribonucleotide reductase (RR) be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds? Biochem. Pharm. (in press).
OGURO, M., SUZUKI-HORI, C., NAGANO, H., MANO, Y. & IKEGAMI, S. (1979). The mode of inhibitory action by aphidicolin on Eukaryotic DNA polymerase. Eur. J. Biochem., 97, 603–607.
OSTRANDER, M. & CHENG, Y.-C. (1980). Properties of Herpes Simplex Virus type I and type II DNA polymerase. Biochim. biophys. Acta., 609, 232–245.
PEDRALI-NOY, G. & SPADARI, S. (1980). Mechanism of Inhibition of Herpes Simplex Virus and Vaccinia Virus DNA polymerases by aphidicolin, a highly specific inhibitor of DNA replication in eucaryotes. J. Virol., 36, 457–464.
PONCE de LEON, M., EISENBERG, R.J. & COHEN, G.H. (1977). Ribonucleotide reductase from Herpes Simplex Virus (types I and II) infected and uninfected KB cells: Properties of the partially purified enzymes. J. Gen. Virol., 36, 163–173.
PRUSOFF, W.H., LIN, T.-S., MANCINI, W.R., OTTO, M.J., SIEGEL, S.A. & LEE, J.J. (1983). Overview of the Possible Targets for Viral Chemotherapy. In Targets for the Design of Antiviral Agents. E. De Clercq & R.T. Walker (eds), pp. 1, New York & London: Plenum Press.
PURIFOY, D.J.M. & POWELL, K.L. (1976). DNA-Binding Proteins Induced by Herpes Simplex Virus Type II in HEP-2 Cells. J. Virol., 19, 717–731.
ROIZMAN, B. (1983). The Herpesviruses, 2. New York: Plenum Press.
WADE, J.C., NEWTON, B., McLAREN, C., FLOURNOY, N., KEENEY, R.E. & MEYERS, J.D. (1982). Intravenous acyclovir to treat Mucocutaneous Herpes Simplex Virus infection after marrow transplantation. Ann. intern. Med., 96, 265–269.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1984 Macmillan Publishers Limited
About this chapter
Cite this chapter
Cheng, Y., Bastow, K., Frank, K., Nutter, L., Chiou, J.F., Grill, S. (1984). Enzymes as antiviral targets. In: Paton, W., Mitchell, J., Turner, P. (eds) IUPHAR 9th International Congress of Pharmacology London 1984. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-17613-7_34
Download citation
DOI: https://doi.org/10.1007/978-1-349-17613-7_34
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-0-333-37134-3
Online ISBN: 978-1-349-17613-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)